ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV (GSK) (PFE)

Go back to ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV (GSK) (PFE)
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 41.17 +0.60 (1.48%)
Previous Close $40.57    52 Week High $45.58 
Open $40.94    52 Week Low $37.82 
Day High $41.17    P/E N/A 
Day Low $40.88    EPS $0.00 
Volume 630,252       

Pfizer Inc. (NYSE: PFE) Delayed: 39.69 +0.10 (0.25%)
Previous Close $39.59    52 Week High $37.39 
Open $39.62    52 Week Low $28.25 
Day High $39.71    P/E 24.05 
Day Low $39.60    EPS $1.65 
Volume 916,379